PATENT CLAIM ANALYSIS

Application Number: 16154478
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "313000"]

Abstract:
The instant application discloses methods of treating, reducing, or preventing pain in a mammal, which may include administering a compound capable of modulating a transient receptor potential channel. In one aspect, the TRP channel may be TRPC4. Types of pain contemplated by the present disclosure include acute, chronic, neuropathic, and nociceptive pain.

Claim (Index 21):
The method of  claim 14 , wherein said compound functions as a Trpc4 antagonist.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14303711', '10987289', '13175366', '14416026', '11431942']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7315400171202213
- 35 USC 102 Novelty (BERT): 0.5553312171569257
- Combined Prediction Score: 0.7139191371238918
- Mean Citation Score: 246.604802
- Max Citation Score: 436.1833
- Similarity Product: 286.9830254983425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test